DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Manns M, Samuel D, Gane EJ. et al.
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

The Lancet infectious diseases 2016;
16: 685-697

Download Bibliographical Data

Access:
Access: